Risk-assessment and coping strategies segregate with divergent intrinsic aerobic capacity in rats

Neuropsychopharmacology

Volumn 36, Issue 2, 2011, Pages 390-401

  Burghardt, Paul R ^a   Flagel, Shelly B ^a   Burghardt, Kyle J ^b   Britton, Steven L ^c   Gerard Koch, Lauren ^c   Watson, Stanley J ^a   Akil, Huda ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

coping; corticosterone; CRH; desipramine; risk assessment; stress

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE;

ADRENAL GLAND; AEROBIC CAPACITY; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BLOOD SAMPLING; BODY WEIGHT; CAT; CLINICAL ASSESSMENT; CONTROLLED STUDY; COPING BEHAVIOR; CORTICOSTERONE BLOOD LEVEL; FORCED SWIMMING TEST; IMMOBILIZATION; INTRINSIC AEROBIC CAPACITY; LOCOMOTION; MENTAL STRESS; NONHUMAN; ODOR; PHENOTYPE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; STRESS; THYMUS; TREADMILL;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; BEHAVIOR, ANIMAL; EXERCISE TOLERANCE; MALE; PHYSICAL CONDITIONING, ANIMAL; RATS; RISK-TAKING; STRESS, PSYCHOLOGICAL;

EID: 78650170798     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.144     Document Type: Article

References (60)

1. Akil H (2005). Stressed and depressed. Nat Med 11: 116-118.
2. Bale TL, Vale WW (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557.
3. Barbato JC, Koch LG, Darvish A, Cicila GT, Metting PJ, Britton SL (1998). Spectrum of aerobic endurance running performance in eleven inbred strains of rats. J Appl Physiol 85: 530-536.
4. Bauer ME, Jeckel CM, Luz C (2009). The role of stress factors during aging of the immune system. Ann N Y Acad Sci 1153: 139-152.
5. Bjornebekk A, Mathe AA, Brene S (2005). The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int J Neuropsychopharmacol 8: 357-368.
6. Blanchard DC, Blanchard RJ, Griebel G (2005). Defensive responses to predator threat in the rat and mouse. Curr Protoc Neurosci (Suppl 30): 8.19.1-8.19.20, Chapter 8, Unit 8, 19.
7. Blanchard DC, Griebel G, Blanchard RJ (2003). Conditioning and residual emotionality effects of predator stimuli: some reflections on stress and emotion. Progr Neuropsychopharmacol Biol Psychiatry 27: 1177-1185.
8. Blanchard RJ, Flannelly KJ, Blanchard DC (1986). Defensive behavior of laboratory and wild Rattus norvegicus. J Comp Psychol 100: 101-107.
9. Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P (2005). Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens 23: 611-617.
10. Britton DR, Koob GF, Rivier J, Vale W (1982). Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 31: 363-367.
11. Britton KT, Morgan J, Rivier J, Vale W, Koob GF (1985). Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology 86: 170-174.
12. Buck BJ, Kerman IA, Burghardt PR, Koch LG, Britton SL, Akil H et al (2007). Upregulation of GAD65 mRNA in the medulla of the rat model of metabolic syndrome. Neurosci Lett 419: 178-183.
13. Burghardt PR, Fulk LJ, Hand GA, Wilson MA (2004). The effects of chronic treadmill and wheel running on behavior in rats. Brain Res 1019: 84-96.
14. Burghardt PR, Pasumarthi RK, Wilson MA, Fadel J (2006). Alterations in fear conditioning and amygdalar activation following chronic wheel running in rats. Pharmacol Biochem Behav 84: 306-312.
15. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C et al (1999). Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451.
16. Dallman MF, Levin N, Cascio CS, Akana SF, Jacobson L, Kuhn RW (1989). Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. Endocrinology 124: 2844-2850.
17. Detke MJ, Rickels M, Lucki I (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121: 66-72.
18. Dielenberg RA, McGregor IS (1999). Habituation of the hiding response to cat odor in rats (Rattus norvegicus). J Comp Psychol 113: 376-387.
19. Dielenberg RA, McGregor IS (2001). Defensive behavior in rats towards predatory odors: a review. Neurosci Biobehav Rev 25: 597-609.
20. Droste SK, Chandramohan Y, Hill LE, Linthorst AC, Reul JM (2007). Voluntary exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the adrenal level. Neuroendocrinology 86: 26-37.
21. Droste SK, Gesing A, Ulbricht S, Muller MB, Linthorst AC, Reul JM (2003). Effects of long-term voluntary exercise on the mouse hypothalamic-pituitary- adrenocortical axis. Endocrinology 144: 3012-3023.
22. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO (2005). Exercise treatment for depression: efficacy and dose response. Am J Prev Med 28: 1-8.
23. Dunn AL, Trivedi MH, O'Neal HA (2001). Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc 33(Suppl): S587-S597;discussion 510-609.
24. Falls WA, Fox JH, Macaulay CM (2009). Voluntary exercise improves both learning and consolidation of cued conditioned fear in C57 mice. Behav Brain Res 207: 321-331.
25. Foley TE, Greenwood BN, Day HE, Koch LG, Britton SL, Fleshner M (2006). Elevated central monoamine receptor mRNA in rats bred for high endurance capacity: implications for central fatigue. Behav Brain Res 174: 132-142.
26. Gonzalez NC, Howlett RA, Henderson KK, Koch LG, Britton SL, Wagner HE et al (2006). Systemic oxygen transport in rats artificially selected for running endurance. Respir Physiol Neurobiol 151: 141-150.
27. Greenwood BN, Foley TE, Burhans D, Maier SF, Fleshner M (2005). The consequences of uncontrollable stress aResensitive to duration of prior wheel running. Brain Res 1033: 164-178.
28. Greenwood BN, Strong PV, Dorey AA, Fleshner M (2007). Therapeutic effects of exercise: wheel running reverses stress-induced interference with shuttle box escape. Behav Neurosci 121: 992-1000.
29. Herring MP, O'Connor PJ, Dishman RK (2010). The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med 170: 321-331.
30. Hoffman MD, Hoffman DR (2008). Exercisers achieve greater acute exercise-induced mood enhancement than nonexercisers. Arch Phys Med Rehab 89: 358-363.
31. Hogg S, File SE (1994). Responders and nonresponders to cat odor do not differ in other tests of anxiety. Pharmacol Biochem Behav 49: 219-222.
32. Hussain SO, Barbato JC, Koch LG, Metting PJ, Britton SL (2001). Cardiac function in rats selectively bred for low- and high-capacity running. Am J Physiol Regul Integr Comp Physiol 281: R1787-R1791.
33. Kabbaj M, Devine DP, Savage VR, Akil H (2000). Neurobiological correlates of individual differences in noveltyseeking behavior in the rat: differential expression of stress-related molecules. J Neurosci 20: 6983-6988.
34. Kask A, Nguyen HP, Pabst R, Von Horsten S (2001). Neuropeptide Y Y1 receptormediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. Neuroscience 104: 799-806.
35. Koch LG, Britton SL (2001). Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol Genom 5: 45-52.
36. Kopelman PG (2000). Obesity as a medical problem. Nature 404: 635-643.
37. Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Vanhala M (2008). Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 69: 178-182.
38. Korte SM, De Boer SF (2003). A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 463: 163-175.
39. Koylu EO, Balkan B, Kuhar MJ, Pogun S (2006). Cocaine and amphetamine regulated transcript (CART) and the stress response. Peptides 27: 1956-1969.
40. Lu A, Steiner MA, Whittle N, Vogl AM, Walser SM, Ableitner M et al (2008). Conditional mouse mutants highlight mechanisms of corticotropin- releasing hormone effects on stress-coping behavior. Mol Psychiatry 13: 1028-1042.
41. Lujan HL, Britton SL, Koch LG, DiCarlo SE (2006). Reduced susceptibility to ventricular tachyarrhythmias in rats selectively bred for high aerobic capacity. Am J Physiol Heart Circ Physiol 291: H2933-H2941.
42. Masini CV, Sauer S, Campeau S (2005). Ferret odor as a processive stress model in rats: neurochemical, behavioral, and endocrine evidence. Behav Neurosci 119: 280-292.
43. Mastorakos G, Zapanti E (2004). The hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone. Nutr Neurosci 7: 271-280.
44. McEwen BS (2000). Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22: 108-124.
45. McEwen BS, Stellar E (1993). Stress and the individual. Mechanisms leading to disease. Arch Intern Med 153: 2093-2101.
46. McIntyre RS, Soczynska JK, Konarski JZ, Woldeyohannes HO, Law CW, Miranda A et al (2007). Should depressive syndromes be reclassified as 'metabolic syndrome type II'? Ann Clin Psychiatry 19: 257-264.
47. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K et al (1984). Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science (New York, NY) 226: 1342-1344.
48. Noland RC, Thyfault JP, Henes ST, Whitfield BR, Woodlief TL, Evans JR et al (2007). Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance. Am J Physiol 293: E31-E41.
49. Novak CM, Escande C, Burghardt PR, Zhang M, Barbosa MT, Chini EN et al (2010). Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity. Horm Behav 58: 355-367.
50. Pentkowski NS, Litvin Y, Blanchard DC, Vasconcellos A, King LB, Blanchard RJ (2009). Effects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats. Horm Behav 56: 35-43.
51. Raikkonen K, Matthews KA, Kuller LH (2007). Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabet Care 30: 872-877.
52. Richardson RD, Omachi K, Kermani R, Woods SC (2002). Intraventricular insulin potentiates the anorexic effect of corticotropin releasing hormone in rats. Am J Physiol 283: R1321-R1326.
53. Spencer RL, Kim PJ, Kalman BA, Cole MA (1998). Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 139: 2718-2726.
54. Tempel DL, Leibowitz SF (1994). Adrenal steroid receptors: interactions with brain neuropeptide systems in relation to nutrient intake and metabolism. J Neuroendocrinol 6: 479-501.
55. Van Hoomissen JD, Holmes PV, Zellner AS, Poudevigne A, Dishman RK (2004). Effects of beta-adrenoreceptor blockade during chronic exercise on contextual fear conditioning and mRNA for galanin and brain-derived neurotrophic factor. Behav Neurosci 118: 1378-1390.
56. Waters RP, Renner KJ, Pringle RB, Summers CH, Britton SL, Koch LG et al (2008). Selection for aerobic capacity affects corticosterone, monoamines and wheel-running activity. Physiol Behav 93: 1044-1054.
57. Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen HU (1993). Sex differences in rates of depression: cross-national perspectives. J Affect Disord 29: 77-84.
58. Wilhelm CJ, Mitchell SH (2009). Strain differences in delay discounting using inbred rats. Genes Brain Behav 8: 426-434.
59. Wisloff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-Share Q et al (2005). Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science (New York, NY) 307: 418-420.
60. Yilmazer-Hanke DM, Faber-Zuschratter H, Linke R, Schwegler H (2002). Contribution of amygdala neurons containing peptides and calcium-binding proteins to fear-potentiated startle and exploration-related anxiety in inbred Roman high- and low-avoidance rats. Eur J Neurosci 15: 1206-1218.